ConductScience.org, home

Trial · NCT07910162

Developing a Gynecologic Cancer Health Promotion Community Engagement Program

NCT07910162, Enrolling by invitation, Abramson Cancer Center at Penn Medicine

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Developing a Gynecologic Cancer Health Promotion Community Engagement Program. Trials, record NCT07910162. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07910162

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Developing a Gynecologic Cancer Health Promotion Community Engagement Program
NCT number
NCT07910162
Status
Enrolling by invitation
Enrollment
100 participants, estimated
Lead sponsor
Abramson Cancer Center at Penn Medicine
Conditions
Gynecologic Cancer Survivors
First posted
2026-11-02
Last updated
2026-11-09

Source ClinicalTrials.gov

Registered outcomes1

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryThemes Identified from Focus Groups and SurveysFrom enrollment to June 2027.
Thematic analysis of transcripts from semi-structured interviews to identify primary thematic categories regarding barriers and facilitators to discussing gynecologic cancer. Count/listing of identified primary qualitative themes will be performed.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07910162

GET https://conductscience.org/api/trials/v1/NCT07910162/registered